In‐Jin Jang
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism 8
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Adverse Reactions 3
- Pharmacology and Obesity Treatment 2
- Gastroenterology top 10%
- Pharmacology top 10%
- Pharmacogenetics and Drug Metabolism 8
- Antibiotics Pharmacokinetics and Efficacy 4
- Drug-Induced Adverse Reactions 3
- Pharmacology and Obesity Treatment 2
-
- Pharmacological Effects and Toxicity Studies 4
- Psychiatry and Mental health top 10%
-
- Diabetes Treatment and Management 3
-
- Metabolomics and Mass Spectrometry Studies 2
-
- Neuroendocrine Tumor Research Advances 2
- Co-authors
- Kyung‐Sang YuJoo‐Youn ChoSang‐Goo ShinSeungHwan LeeDong‐Ryul SohnJae‐Gook ShinBo‐Hyung KimSeo Hyun Yoon
- Cited by
- PharmacologyGastroenterology
- Journals
- Epilepsia (4 papers)Clinical Pharmacology & Therapeutics (3 papers)Alimentary Pharmacology & Therapeutics (1 paper)
- Partner nations
- South KoreaUnited StatesEthiopia
In The Last Decade
In‐Jin Jang
26 papers receiving 641 citations
Peers
Comparison fields: 5 of 80
- Pharmacology 222
- Gastroenterology 54
- Pharmacology 146
- Pediatrics, Perinatology and Child Health 123
- Psychiatry and Mental health 91
Countries citing papers authored by In‐Jin Jang
This map shows the geographic impact of In‐Jin Jang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by In‐Jin Jang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites In‐Jin Jang more than expected).
Fields of papers citing papers by In‐Jin Jang
This network shows the impact of papers produced by In‐Jin Jang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by In‐Jin Jang. The network helps show where In‐Jin Jang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside In‐Jin Jang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2021 | 11 | |
| 3 | 2021 | 4 | |
| 4 | 2020 | 21 | |
| 5 | 2020 | 4 | |
| 6 | 2020 | 25 | |
| 7 | 2020 | 7 | |
| 8 | 2019 | 9 | |
| 9 | 2017 | 11 | |
| 10 | 2016 | 23 | |
| 11 | 2015 | 37 | |
| 12 | 2012 | 58 | |
| 13 | 2011 | 13 | |
| 14 | 2008 | 58 | |
| 15 | 2008 | 32 | |
| 16 | 2002 | 38 | |
| 17 | 2000 | 4 | |
| 18 | 1993 | 51 | |
| 19 | 1992 | 15 | |
| 20 | 1992 | 107 |
About In‐Jin Jang
In‐Jin Jang is a scholar working on Pharmacology, Pharmacology and Gastroenterology, having authored 27 papers that have together received 660 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (8 papers), Pharmacological Effects and Toxicity Studies (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers), Drug-Induced Adverse Reactions (3 papers), Diabetes Treatment and Management (3 papers), Metabolomics and Mass Spectrometry Studies (2 papers), Pharmacology and Obesity Treatment (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Pharmacology (222 citations), Gastroenterology (54 citations) and Pharmacology (146 citations). In‐Jin Jang has collaborated with scholars based in South Korea, United States and Ethiopia. Frequent co-authors include Kyung‐Sang Yu, Joo‐Youn Cho, Sang‐Goo Shin, SeungHwan Lee, Dong‐Ryul Sohn, Jae‐Gook Shin, Bo‐Hyung Kim, Seo Hyun Yoon, Takashi Ishizaki and Kyoung Soo Lim. Their work appears in journals such as Epilepsia, Clinical Pharmacology & Therapeutics and Alimentary Pharmacology & Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.